Used in pharmaceutical research as a key intermediate in the synthesis of central nervous system agents, particularly in the development of selective serotonin reuptake inhibitors (SSRIs) and related antidepressant compounds. Its structural configuration allows for strong interaction with neurotransmitter receptors, enhancing bioavailability and receptor binding affinity. Also explored in the design of dopamine modulators for treating neurological disorders such as Parkinson’s disease and schizophrenia. Due to its lipophilic nature and ability to cross the blood-brain barrier efficiently, it is favored in the formulation of neuroactive drugs. Additionally, it serves as a building block in medicinal chemistry for optimizing pharmacokinetic properties in novel drug candidates.